O
CRL icon

Ossiam’s Charles River Laboratories CRL Stock Holding History

Ossiam’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.4K Buy
+200
New +$35.6K ﹤0.01% 635
2025
Q2 		– Sell
-268
Closed -$40.3K – 644
2025
Q1 		$40.3K Sell
268
-533
-67% -$89.4K ﹤0.01% 580
2024
Q4 		$148K Sell
801
-75
-9% -$14.4K ﹤0.01% 542
2024
Q3 		$173K Buy
876
+837
+2,146% +$174K ﹤0.01% 550
2024
Q2 		$8.06K Buy
39
+30
+333% +$6.8K ﹤0.01% 622
2024
Q1 		$2.44K Sell
9
-664
-99% -$159K ﹤0.01% 626
2023
Q4 		$159K Buy
673
+9
+1% +$1.77K ﹤0.01% 603
2023
Q3 		$130K Sell
664
-24
-3% -$4.93K ﹤0.01% 622
2023
Q2 		$145K Buy
688
+278
+68% +$55.3K ﹤0.01% 632
2023
Q1 		$82.7K Sell
410
-97
-19% -$22K ﹤0.01% 632
2022
Q4 		$110K Hold
507
– – ﹤0.01% 564
2022
Q3 		$100K Buy
+507
New +$109K ﹤0.01% 564
2022
Q2 		– Sell
-887
Closed -$252K – 449
2022
Q1 		$252K Sell
887
-765
-46% -$236K 0.01% 355
2021
Q4 		$622K Buy
1,652
+359
+28% +$139K 0.02% 296
2021
Q3 		$534K Sell
1,293
-188
-13% -$78.1K 0.02% 294
2021
Q2 		$603K Buy
+1,481
New +$495K 0.02% 297

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Ossiam's CRL Position: Q2 2026 in Review

Ossiam opened a new position in Charles River Laboratories (CRL) in Q2 2026: 200 shares worth $45.4K. The stake represents ﹤0.01% of the portfolio and ranks #635 among its holdings. This is a return to the name: Ossiam previously reported a position in CRL as recently as Q1 2025.

Ossiam first reported a position in CRL in Q2 2021 and has held it in 16 quarters since. The position peaked at $622K in Q4 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Ossiam held 200 shares of Charles River Laboratories worth $45.4K as of Q2 2026.
  • Charles River Laboratories was a new Ossiam position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Ossiam's portfolio in Q2 2026, its #635 holding.
  • Ossiam first reported a position in Charles River Laboratories in Q2 2021 and has held it in 16 quarters since.
  • Ossiam's Charles River Laboratories position peaked at $622K in Q4 2021.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.